Mammographic density as an image-based biomarker of therapy response in neoadjuvant-treated breast cancer patients.

It seemed as though patients with higher MD at baseline were less likely to reach pCR after NACT-a finding more pronounced in premenopausal women. Larger multicenter studies are needed to enable analyses and interpretation for different BC subtypes.